Discover EIBIR’s Sessions at ECR 2027
Discover EIBIR’s Sessions at ECR 2027
We are happy to be sharing with you dedicated sessions and other activities hosted by EIBIR at the European Congress of Radiology (ECR) 2027, taking place from March 3–7, 2026, in Vienna and online via ESR Connect.
EIBIR Sessions
EIBIR 2 – Apply AI: how Europe is bringing medical AI from policy to practice
Wednesday, March 3, 2027 | 10:00–11:00 | Room TBC
Discover how Europe is turning trustworthy AI into clinical reality through insights from Compass AI, and RadioVal, exploring AI policy, deployment guidelines, literacy, validation frameworks, regulatory readiness, and responsible implementation of AI in healthcare and medical imaging.
EIBIR 5 – AI meets obesity: from promise to trustworthy cardiovascular risk prediction
Wednesday, March 3, 2027 | 15:00–16:00 | Room TBC
Explore AI‑POD’s innovative approach to cardiovascular risk prediction in obesity, combining imaging, clinical, and lifestyle data through explainable AI risk scores, clinical decision support tools, wearable monitoring, and patient-centred solutions designed for trustworthy and impactful healthcare.
EIBIR 6 – Stop reinventing the wheel: European insights for sharing medical images for AI research
Wednesday, March 3, 2027 | 16:30–17:30 | Room TBC
Find out how Europe is advancing secure and responsible medical imaging data sharing through initiatives such as Compass AI and ODELIA, exploring health data policies, governance best practices, privacy-preserving technologies, and innovative collaboration models that enable trustworthy AI research across borders.
EIBIR 8 – Open, curated, compliant: European approach to sharing cancer imaging data for AI development
Thursday, March 4, 2027 | 10:00–11:00 | Room TBC
Explore how EUCAIM is transforming cancer imaging research through a federated European infrastructure, empowering healthcare institutions and researchers to securely share, access, and leverage high-quality cancer imaging data for collaborative research and trustworthy AI development.
EIBIR 12 – The future of interventional care: can smart assistance and advanced imaging deliver true precision?
Friday, March 5, 2027 | 08:00–09:00 | Room TBC
Discover how the IHI projects SHERPA and PreciseOnco are advancing the future of interventional radiology through human-centred AI, robotics, and next-generation imaging technologies, addressing workforce challenges, supporting clinical decision-making, and enabling more precise, standardised treatments for cancer and neurovascular patients.
EIBIR 16 – The RHYTHM project: shaping safer paediatric imaging in Europe
Friday, March 5, 2027 | 16:00–17:30 | Room TBC
Explore the latest advances in paediatric imaging across Europe with RHYTHM, from radiation safety and clinical best practices to AI-driven data analysis and patient-centred care, highlighting how collaboration, shared imaging data, and informed families can contribute to safer and more effective imaging for children.
EIBIR 19 – Is more data the answer? Technology, trust, and impact in European breast cancer screening
Saturday, March 6, 2027 | 12:30–13:30 | Room TBC
Explore how BreastSCan is building a pan-European ecosystem for breast cancer imaging, bringing together high-quality data, FAIR and federated infrastructures, and patient engagement to advance AI-driven research, improve screening and diagnosis, and strengthen the future of personalised breast cancer care.
EIBIR 20 – CLAUD-IT conclusions: spreading the word on clinical audit
Saturday, March 6, 2027 | 14:00–15:00 | Room TBC
Discover how the CLAUD-IT project is strengthening clinical audit practices across Europe through structured training, peer-to-peer knowledge transfer, and multi-country hospital audits, fostering quality improvement, patient safety, and greater implementation of clinical audit in radiology and nuclear medicine.
EIBIR Booth Sessions
(onsite only, Austria Center level 1)
More details coming soon…
EIBIR Studio Sessions
(online only, open access)
More details coming soon…
Visit us any time at the EIBIR booth!
The EIBIR booth will showcase the latest results from our EU-funded research projects and highlighting opportunities for collaboration and funding in biomedical imaging.
Join us at ECR 2027 to engage with Europe’s leading experts in imaging research and innovation — and to see how EIBIR-supported projects continue to shape the future of medical imaging!
SOLACE+ launches under EIBIR coordination to scale up lung cancer screening across Europe
SOLACE+ (Strengthening the screening of Lung Cancer in Europe – Pilots, Learning, Uptake and Sustainability) launched on 1 November 2026, bringing together 46 partners from 22 EU Member States and Norway, to implement equitable, high-quality lung cancer screening programmes with AI-assisted workflows.
The launch of the project, coincides with Lung Cancer Awareness Month, underscoring the urgent need for action on Europe’s deadliest cancer.
The 3-year project, co-funded by the EU4Health Programme, builds on the achievements of the original SOLACE project, which was also coordinated by EIBIR and screened over 30,000 people across 11 countries, demonstrated that targeted outreach reaches groups often missed by screening and influenced national screening policy in a number of countries.
SOLACE+ directly supports Europe’s Beating Cancer Plan, the EU’s comprehensive framework to tackle cancer from prevention to treatment and survivorship. The project contributes to the Plan’s early detection pillar by helping Member States implement the Council Recommendation on cancer screening, which includes lung cancer screening for high-risk groups.
SOLACE+ will support Member States to design, plan, launch, evaluate and optimise low-dose CT (LDCT)-based lung cancer screening programmes. The project focuses on reaching high-risk and vulnerable populations, strengthening quality assurance and workforce capacity, integrating AI responsibly into radiological workflows and addressing remaining gaps including smoking cessation and adherence after baseline screening.
The project will evaluate and implement AI-assisted tools for nodule detection, risk stratification and workflow optimisation. These technologies support radiologists by improving detection accuracy, reducing reading time and enabling consistent quality across screening sites, while maintaining human oversight and clinical judgment.
Rozemarijn Vliegenthart, Scientific Co-Coordinator of the SOLACE+ project, said:
“Within SOLACE+ we will support 19 countries to build screening programmes that are sustainable, equitable and grounded in real-world evidence. That is how we turn lung cancer screening from a goal into practice.”
Torsten Blum, Scientific Co-Coordinator of the SOLACE+ project, added:
“Screening saves lives if people can access it and quality is consistent. SOLACE proved that targeted outreach works. We screened over 30,000 people across 11 countries and reached groups who are often missed. SOLACE+ is about taking what we learned and making it work at scale.”
Monika Hierath, EIBIR Executive Manager, assures EIBIR ‘s full support of the project:
“We are proud that, following the successful closure of SOLACE, the lung cancer screening community also entrusted EIBIR with the coordination of its successor project SOLACE+. We will do our utmost to ensure the project delivers on its promises and achieves its ambitious objectives and look forward to taking lung cancer screening in Europe to the next level in collaboration with our 45 fellow partners.”
The project is scientifically led by Rozemarijn Vliegenthart and Torsten Blum with the support of Joanna Chorostowska-Wynimko and Helmut Prosch, representing the European Respiratory Society and the European Society of Radiology. The project brings together universities, university hospitals, health authorities, professional associations, patient organisations and research institutions from across Europe.
SOLACE+ aims to utilise this collaboration to deliver positive health outcomes at the individual level. By establishing sustainable screening programmed, the project aims to make early detection a reality for thousands more people.
Lung cancer is the leading cause of cancer death in Europe, responsible for over 250,000 deaths annually. Every November, Lung Cancer Awareness Month highlights the urgent need for action on this preventable tragedy. Evidence shows that LDCT screening can reduce lung cancer deaths, but implementation remains uneven across Member States. SOLACE+ addresses this by creating a coordinated cross-country implementation network, developing common standards, and building sustainable capacity for the long term – all aligned with Europe’s Beating Cancer Plan objectives.
For more information, please visit our SOLACE+ section.
The SOLACE+ project is co-funded by the European Union’s EU4Health programme under Grant Agreement No. 101314323.
EIBIR encourages the imaging community to join the EHDS Stakeholder Community
The European Institute for Biomedical Imaging Research (EIBIR) encourages its members and partners to register for the newly established EHDS Stakeholder Community, a European Commission initiative supporting stakeholder engagement in the implementation of the European Health Data Space (EHDS).
For the biomedical imaging community, participation is particularly important. Through its coordination of EUCAIM (European Federation for Cancer Images), EIBIR is already contributing to the development of a federated European infrastructure for cancer imaging data. The experience gained through EUCAIM provides valuable insights into many of the challenges that EHDS seeks to address, including interoperability, secure data access, AI development, governance and cross-border collaboration.
The EHDS Stakeholder Community offers a platform where these practical experiences can contribute to discussions around EHDS implementation. Members can exchange expertise with stakeholders from across Europe, access resources and guidance, and participate in webinars, consultations and discussions on the future of health data sharing and reuse.
Why your participation matters
The successful implementation of EHDS will be critical for the future use of medical imaging data in healthcare, research and innovation. Imaging stakeholders have a unique opportunity to ensure that existing investments in European infrastructures, including EUCAIM/Cancer Image Europe, are effectively connected with the emerging EHDS framework.
By joining the Stakeholder Community, you can:
- Contribute imaging expertise to EHDS implementation discussions
- Share practical experience from European imaging research infrastructures
- Stay informed about policy and technical developments
- Build connections across the European health data ecosystem
- Help maximise the impact and sustainability of projects such as EUCAIM
Strong engagement from the imaging community will help ensure that EHDS supports innovation while enabling secure, trustworthy and effective use of health data for the benefit of patients, researchers and healthcare systems.
How to register
The EHDS Stakeholder Community is hosted on the EU Health Policy Platform and is open to organisations and individuals working with health data across Europe. Interested stakeholders can register through the European Commission’s EHDS Stakeholder Community webpage and gain access to community activities, resources and discussions.
Join our webinar: Breast Cancer Diagnosis and Treatment Reimagined: AI-Supported Breast Oncology
Explore AI-supported breast oncology with ODELIA, RadioVal and BreastSCan on 5th November 2026, from 12:00 to 13:00 CET.
Artificial intelligence is transforming cancer screening, diagnosis and care. Bringing these innovations into clinical practice requires robust data infrastructures, reliable validation frameworks and AI models that perform across diverse healthcare settings.
The online webinar “Breast Cancer Diagnosis and Treatment Reimagined: AI-Supported Breast Oncology” brings together the ODELIA, RadioVal and BreastSCan projects to explore these technical foundations. Experts will share perspectives on AI development, validation and imaging infrastructure, highlighting the challenges and opportunities of translating innovation into real-world clinical impact.
Participants will discover approaches to developing robust, generalisable AI models across healthcare institutions and learn how European collaborative initiatives are advancing AI in breast oncology. A panel discussion will offer the opportunity to ask questions and engage with the speakers.
Moderator
Derya Yakar
University Medical Center Groningen, Netherlands
Speakers and topics
Speakers and topics:
Carlos Telleria Orriols
Instituto Aragonés de Ciencias de la Salud (IACS), Spain
AI-ready federated infrastructure to improve breast cancer screening
Jakob Nikolas Kather
University Hospital Heidelberg (UKHD), Germany
Building Generalisable AI for Breast MRI
Oliver Diaz
University of Barcelona, Spain
The Pain Behind Trustworthy AI: From Data to Clinical Applications
Date: 5th November 2026
Time: 12:00–13:00 CET
Format: Online webinar
EIBIR joins the European Cardiovascular Health data and AI Network (CHAIN) kick-off
EIBIR is pleased to be a partner in CHAIN, the European Cardiovascular Health data and AI Network.
CHAIN is a three-year European collaboration for trustworthy AI in cardiovascular and related non-communicable disease care coordinated by the European Society of Cardiology and co-funded by the European Union’s EU4Health programme. It brings together 53 partners from 20 countries to help close the gap between promising AI solutions and their safe, effective and scalable use in cardiovascular care. CHAIN will connect a federated data ecosystem, AI evaluation and deployment services, regulatory support and six real-world use cases to generate practical evidence, tools and guidance for healthcare systems across Europe.
Building on its extensive experience in European biomedical imaging research and health data initiatives, including coordination of EUCAIM, EIBIR plays a key role in the CHAIN project by bringing in its expertise from EUCAIM and the COMPASS-AI Flagship fostering collaboration with major European health data and AI initiatives, supporting engagement of the imaging community and other stakeholders, and contributing to the long-term sustainability of the project’s outcomes. Through its established networks in medical imaging, digital health and research and data infrastructures, EIBIR contributes to the dissemination of project results, supports the development of a European community of practice for AI in cardiovascular health, and helps ensure that CHAIN’s innovations can be sustainably adopted and scaled across diverse healthcare settings.
Partners meet on 7-8 October 2026 in Sophia Antipolis, France, to kick off this ambitious collaboration.
Stay tuned for updates!
EIBIR at the Forefront of Europe’s AI for Health Ambitions
European Commission President von der Leyen highlights AI-supported mammography as a model for “AI for Health”
In her 2026 State of the Union address to the European Parliament on 16 September, European Commission President Ursula von der Leyen chose breast cancer screening as a leading example of how artificial intelligence can transform healthcare in Europe. She noted that breast cancer screening already reduces mortality by around 30-40% among women who participate and argued that AI can further improve outcomes by helping detect cancers earlier and more accurately, enabling more women to survive the disease.
At the same time, she stressed that Europe must pursue this transformation “in a European way”, with AI supporting clinicians rather than replacing them. As she put it: “AI needs to empower our doctors. Not to replace them.”
Von der Leyen identified healthcare as one of the highest-value sectors for AI deployment, highlighting both its transformative potential and Europe’s wealth of high-quality health data.
EIBIR coordinates Europe’s flagship AI and cancer initiatives
In line with this mission, the European Institute for Biomedical Imaging Research (EIBIR), established by and headquartered at the European Society of Radiology (ESR) coordinates the implementation of flagship initiatives under Europe’s Beating Cancer Plan and the EU Apply AI Strategy. These initiatives seek to develop the infrastructure, connect high-quality datasets and establish guidance for the safe clinical deployment of AI, reflecting the “European way” of using health data responsibly while fostering innovation.
Cancer Image Europe (EUCAIM), the federated European infrastructure for cancer imaging data implementing the European Cancer Imaging Initiative and co-funded under the Digital Europe Programme provides a secure, GDPR- and EHDS-compliant cross-border architecture enabling datasets to be discovered, accessed and used for AI training and validation without centralising patient-identifiable data. This exemplifies the “European way” of using health data responsibly while fostering innovation. IIS La Fe holds the scientific coordination of EUCAIM, led by Dr. Martí-Bonmatí, Director of the Medical Imaging Department at La Fe University and Polytechnic Hospital, while UPV, through Prof. Ignacio Blanquer, provides the technical leadership of EUCAIM’s central infrastructure hub.
EUCAIM has become the trusted infrastructure for a growing number of research and implementation projects.
Among them the BreastSCan project, also coordinated by EIBIR and co-funded under the EU4Health Programme, builds on EUCAIM to train and validate AI tools for image quality assessment, risk stratification, lesion detection and breast density classification. The project also promotes the AI literacy needed for clinicians to use these technologies safely and effectively. BreastSCan is assembling one of the world’s largest and most diverse breast imaging datasets, comprising more than one million mammography, ultrasound and MRI images from over 7,500 confirmed breast cancer cases. Prof. Francesco Sardanelli from La Lega Italiana per la Lotta contro i Tumori (IT), acts as scientific coordinator and Dr. Carlos Telleria from Instituto Aragnes de Ciencias de la Salud (ES) acts as technical coordinator.
Another flagship initiative driven by the radiology community is COMPASS AI, which aims to promote the responsible and effective integration of AI into clinical practice. The project is scientifically coordinated by Prof. Prof. Regina Beets-Tan, University of Maastricht (NL), and Laurens Topff, MD PhD, at the Dutch National Cancer Institute (NL) with EIBIR as project management partner. It focuses on two priority areas: cancer care and healthcare delivery in remote and underserved regions. Bringing together hospitals, professional societies and major European AI-health initiatives, COMPASS AI will establish an interactive platform to share best practices, support knowledge exchange and develop guidance on AI deployment. The project will also contribute to strengthening AI literacy among healthcare professionals, hospital managers and patients.
EIBIR in support of Europe’s AI strategy
EIBIR is closely engaging with the European Commission to identify and leverage synergies between the projects, and to ensure implementation and dissemination efforts align with the EU’s policy perspectives, supporting the European approach to AI: one that is safe, trustworthy, responsible, accessible and resource-conscious, while delivering tangible benefits for patients and healthcare systems and ensuring Europe’s competitiveness in the field.
For more information on EIBIR of if you would like to work with us to turn your project idea into reality, please reach out to us at office@eibir.org.
EUCAIM, Compass AI and SCOPE-AI at the Apply AI Summit
On the occasion of the first anniversary of the Apply AI Strategy and closing the first edition of the European AI Innovation Month, the European Commission is preparing the Apply AI Summit:
EUCAIM and Compass AI are invited to participate with a joint booth to present their results!
You can find us in the AI in Health exhibition area where successful real-world applications of AI solutions in healthcare are featured.
EUropean Federation for CAncer IMages (EUCAIM) is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of Europe’s Beating Cancer Plan (EBCP), which aims to foster innovation and deployment of digital technologies in cancer treatment and care to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients. EUCAIM’s mission is to build a pan-European digital federated infrastructure of cancer-related images, which will be used for the development of AI tools toward Precision Medicine. We hope that this infrastructure will provide the means to develop AI tools that will be able to enhance the (cancer) diagnosis procedure, treatment and the identification of the need for predictive medicine benefiting patients across Europe.
Get in touch with EUCAIM by email: contact@cancerimage.eu
Visit the project website for more information: https://cancerimage.eu/
Community Of Multidisciplinary Professionals Advancing Safe and Successful AI Implementation in Clinical Practice (Compass AI) is a 48-month project co-funded by the European Union under the EU4Health programme 2021–2027 aiming to overcome critical barriers to the safe and effective deployment of AI in healthcare by developing scalable, equitable solutions, with a focus on cancer care and remote regions.The project will build upon FUTURE-AI, an established framework for trustworthy AI in healthcare according to six guiding principles: fairness, universality, traceability, usability, robustness, and explainability. By integrating insights from the expert community, best-practice AI deployment guidelines will be defined and validated through four real-world pilot studies conducted across European countries, in diverse healthcare settings and clinical practices.
Get in touch with Compass AI by email: info@compassai.eu
Visit the project website for more information: http://compassai.eu/
SCaling Oncology Pilots across Europe with imaging and AI (SCOPE-AI) bridges the crucial gap between early AI prototypes and everyday clinical care. Funded under the Digital Europe Programme, the project acts as a practical testing ground that helps developers, startups, and smaller companies bring their healthcare technologies to the market faster, with a clear focus on multimodal AI that combines medical imaging with data from pathology, genomics, or clinical records. To do this, SCOPE-AI builds on the Cancer Image Europe platform and extends it with new services for validating AI solutions. This includes matchmaking that connects AI innovators with suitable datasets and clinical sites, a framework for upscaling AI models to multi-centre and multimodal data, and technical verification before tools enter the hospital. Following trusted guidelines and deployment procedures from Compass AI, these services safely introduce new AI solutions directly into hospital workflows. By coordinating extensive real-world tests for 15 AI tools across at least 8 European clinical centres, the project gathers the concrete evidence needed to show whether these technologies are effective, cost-efficient, and practical for daily use. Lessons learned feed back into updated FUTURE-AI guidelines and training for healthcare professionals. Ultimately, this helps promising AI models make the leap towards certified, ready-to-use tools that improve cancer diagnosis and patient care across Europe, while establishing Cancer Image Europe as a lasting European service for AI validation.
Get in touch with SCOPE-AI by email: office@eibir.org
The Apply AI Summit aims to showcase how trustworthy, human-centric AI is driving competitiveness in key sectors of the European economy, with panel discussions and hands-on demonstrations. Healthcare is one of the priority sectors that will be featured, and one of the main discussion topics of the event will be accelerating the adoption of AI in strategic sectors, including healthcare.
🌟Where? At The EGG in Brussels
🌟When? On November 17, 2026
More information on the program is available here: https://digital-strategy.ec.europa.eu/en/policies/apply-ai-summit
Meet EIBIR’s projects in person
As part of its commitment to advancing medical research and innovation, EIBIR’s project will actively participate in a series of major scientific congresses, conferences, and networking events across Europe until the end of 2026. Through its presence at these key events, EIBIR continues to support the development of high-quality imaging research, promote innovation, and strengthen connections within the European and international community. Discover where you can meet us in the coming months and learn more about our activities, projects, and opportunities for collaboration.
September 2026
PreciseOnco and SHERPA will participate with a joint booth to present the next innovation in interventional oncology
EUCAIM will participate with a booth to present the pan-European federated infrastructure for cancer images
more information here >
HyperProbe will participate with a booth to present how they are revolutionising brain surgery through spectral imaging and AI
EUCAIM, ODELIA and BreastSCan will hold several talks during the event:
13:30 – 13:50 Funding the Future of MRI Research: European Opportunities and Upcoming Calls.
Monika Hierath, EIBIR Executive Manager
13:50 – 14:10 Turning Ideas into Funded Projects: How EIBIR Supports Your Path to European Funding – Lessons from EUCAIM and ODELIA.
Katharina Krischak, EIBIR Senior Project Manager
14:30- 15:00 Panel Discussion.
Prof. Luis Marti-Bonmati (La Fe Hospital University)
October 2026
EUCAIM and BreastSCan will hold different talks during the conference
more information here >
EUCAIM and BreastSCan will participate with a booth to present their activities to advance cancer care
Partners will hold different talks during the conference.
more information here >
EUCAIM, CARE, CLAUD-IT and RHYTHM will participate with a booth to present their activities to advance cancer care.
more information here >
EUCAIM, will participate with a booth to present their activities to advance cancer care
Partners are also invited as speakers.
more information here >
November 2026
BreastSCan and Compass AI will will hold different talks during the conference.
more information here >
Compass AI and EUCAIM will participate with a booth to present their contribution to the Apply AI Strategy.
Partners are also invited as panelists:
14.00 – 14.45 Parallel Session on AI in Healthcare sector.
Prof. Luis Martí Bonmati (La Fe Hospital University) and Prof. Regina Beets-Tan (Maastricht University)
2nd call to join the Euopean Network of AI-Powered Advanced Screening Centres
The European Commission has reopened its call for healthcare organisations to join the European Network of AI-Powered Advanced Screening Centres, a flagship of the Apply AI Strategy expected to cover all EU Member States by the end of 2029.
Joining the Network offers organisations the opportunity to become part of a growing European community dedicated to ensuring the safe, effective and trustworthy use of artificial intelligence in healthcare. Centres can participate in piloting AI solutions in clinical environments and collaborative studies on AI performance.
270 healthcare organisations have already joined the Network in the first call.
If your institution has not yet become a member, there is still time to express your interest and apply!
Click to apply by 10 September! Click to find more information! Please note at the bottom the list of benefits for centres and link to the terms of reference.
This is an excellent opportunity for hospitals, research institutions, screening centres and healthcare organisations across Europe to contribute to the future of innovative healthcare and collaborate with peers at the European level.
EIBIR Booth Sessions at ECR 2027 – Showcase Your Research in Biomedical Imaging
The European Institute for Biomedical Imaging Research (EIBIR) is pleased to host dedicated booth sessions at the European Congress of Radiology (ECR) 2027 in Vienna/Austria on 3-7 March 2027, showcasing cutting-edge research in biomedical imaging.
These booth sessions will feature oral poster presentations selected from submissions to the EIBIR category*, offering researchers a unique platform to present and discuss their work. This will provide the presenters with another opportunity to increase the visibility of their work in the EIBIR research community and the biomedical imaging landscape.
Poster submissions are invited to the following EIBIR topics:
- AI in Radiology (AI, oncologic, cardiovascular and neuro-imaging)
- Emerging technologies
- Hybrid imaging in oncology and cardiovascular disease
- Integrated diagnostics
- Multidisciplinary research and collaboration
All submitted posters undergo a thorough review process by esteemed members of the EIBIR Scientific Advisory Board, ensuring that high-quality, impactful research is presented. Selected authors will have the opportunity to deliver a short oral presentation of their poster at the EIBIR booth during ECR 2027, providing greater visibility and engagement with the ECR audience. Selected authors will be informed in due time about their participation. The best poster will also be awarded with the EIBIR Poster Award.
We encourage all researchers to submit their work for EIBIR Booth Sessions and to take part in this exciting opportunity at ECR 2027.
Join us to explore innovative projects and connect with leading experts in the field.
Abstract submission will run from 3 August to 30 September 2026.
Authors submitting an abstract for the EIBIR Booth Sessions are kindly requested to follow the submission steps below:
- Under Preferred Presentation Format, please select Poster Presentation.
- Under Poster Presentation Format, choose EIBIR Booth Session.
- Finally, select the relevant topic from the list provided above under Topic.
To submit your poster abstract, click here.
If you have any questions on the EIBIR Booth Sessions, please contact the EIBIR team at office@eibir.org.